Elevated monoamine levels in the cerebral hemispheres of microencephalic rats treated prenatally with methylazoxymethanol or cytosine arabinoside.
D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology*; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003561:Cytarabine / Q000494:pharmacology*; D004247:DNA / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D008746:Methylazoxymethanol Acetate / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014365:Tryptophan Hydroxylase / Q000378:metabolism
D001391:Azo Compounds; D001679:Biogenic Amines; D003561:Cytarabine; D012701:Serotonin; D008746:Methylazoxymethanol Acetate; D004247:DNA; D014365:Tryptophan Hydroxylase; D004298:Dopamine; D009638:Norepinephrine